According to the Food and Drug Administration there may be a link between patients with Type 2 Diabetes who take the blood pressure medication Benicar and a higher risk of death from cardiovascular issues. The FDA approved the sale of Benicar in 2002 which is developed by Daiichi Sankyo.
Benicar is in a group of medications called angiotensin-receptor blocks which are used to treat high blood pressure kidney disease and heart problems in patients with diabetes. The FDA is continuing to monitor the medication.
Commentary
When an injury occurs from a medication a meticulous investigation is needed to link that injury with use of the drug. This can be quite difficult for a number of reasons as health conditions can arise from other exterior factors as well as medications.
To have standing for a drug injury claim the aforementioned link must be firmly expressed and injuries incurred from this use must be such that warrant filing a claim against a manufacturer. In other words a reaction of nausea that keeps a person out of work for a day probably does not warrant the costs of filing a lawsuit. However the study notes a potential risk of death from use of the drug. As any reasonable person would assume this is well beyond the realm of minor effects and would certainly meet the threshold of quantitative injuries.
Texas Drug Injury Attorney Michael Grossman
*We appreciate your feedback and welcome anyone to comment on our blog entries, however all visitor blog comments must be approved by the site moderator prior to showing live on the site. By submitting a blog comment you acknowledge that your post may appear live on the site for any visitors to see, pending moderator approval. The operators of this site are not responsible for the accuracy or content of the comments made by site visitors. By submitting a comment, blog post, or email to this site you acknowledge that you may receive a response with regard to your questions or concerns. If you contact Grossman Law Offices using this online form, your message will not create an attorney-client relationship and will not necessarily be treated as privileged or confidential! You should not send sensitive or confidential information via the Internet. Since the Internet is not necessarily a secure environment, it is not possible to ensure that your message sent via the Internet might be kept secure and confidential. When you fill out a contact or comment form, send us an email directly, initiate a chat session or call us, you acknowledge we may use your contact information to communicate with you in the future for marketing purposes, but such marketing will always be done consistent with the advertising ethics rules established by the State Bar of Texas and you will have the option to opt out of future communications.
